n-methyl-3,4-methylenedioxyamphetamine has been researched along with naltrindole in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amendola, CA; Fishkin, MD; Hubbell, CL; Reid, LD; Tsai, J | 1 |
Belkaï, E; Marie-Claire, C; Noble, F; Scherrmann, JM | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and naltrindole
Article | Year |
---|---|
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation.
Topics: Animals; Brain; Electric Stimulation; Male; Medial Forebrain Bundle; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Self Stimulation; Serotonin Agents | 1996 |
Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Brain; Choice Behavior; Conditioning, Classical; Enkephalins; Gene Expression; Hallucinogens; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Pro-Opiomelanocortin; Protein Precursors; Receptors, Opioid, delta; RNA, Messenger; Social Environment; Transcription, Genetic | 2009 |